Company: PIII
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001832511-25-000025
Chunk: 153

Company: P3 Health Partners Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 153
---
 million and a gain of $5.7 million from changes in the fair value of stock warrants for the three months ended September 30, 2025 and 2024, respectively, and gains of $2.8 million and $14.6 million from changes in the fair value of stock warrants for the nine months ended September 30, 2025 and 2024, respectively.The book value of cash; clinic fees, insurance receivables, and other receivables; accounts payable; and accrued expenses and other current liabilities approximate fair value because of the short maturity and high liquidity of these instruments.

P3 Health Partners Inc. | Q3 2025 Form 10-Q | 15

Note 6: Property and EquipmentThe Company’s property and equipment balances consisted of the following:September 30, 2025December 31, 2024(in thousands)Leasehold improvements$2,401 $2,332 Furniture & fixtures951 1,106 Computer equipment & software6,949 7,060 Medical equipment1,013 1,082 Software (development in process)— 343 Vehicles633 659 Other55 — 12,002 12,582 Less: accumulated depreciation(8,100)(6,848)Property and equipment, net$3,902 $5,734 Total depreciation of property and equipment recognized on the condensed consolidated statements of operations was $0.5 million and $0.6 million for the three months ended September 30, 2025 and 2024, respectively, and $1.7 million and $1.7 million for the nine months ended September 30, 2025 and 2024, respectively.Assets Held for SaleOn November 30, 2024, the Company and certain of its subsidiaries (the “Sellers”) entered into an asset purchase agreement with certain entities affiliated with an entity in which Chicago Pacific Founders (“CPF”), the Company’s principal stockholder, has an ownership interest (the “Buyers”), which was amended on December 30, 2024, effective as of December 5, 2024 (as amended, the “Florida Asset Purchase Agreement”). Pursuant to the Florida Asset Purchase Agreement, the Sellers sold to the Buyers all of the assets, clinical and non-clinical, exclusively or primarily used by the Company’s MA-related business operated out of Eagle Park, Florida (the “Florida Assets”). On May 1,